对抗基诺耐药性大肠杆菌 (Escherichia coli) 的反感性-核酸的开发
Se Kye Kim1, Jun Bong Lee1, Hyung Tae Lee1
1College of Veterinary Medicine & Institute of Veterinary Science, Kangwon National University, Chuncheon, Gangwon 24341, Republic of Korea.
The Journal of antimicrobial chemotherapy
|June 30, 2023
概括
反义-核酸 (P-PNAs) 显示出作为新型抗生素对抗诺基诺耐药细菌的承诺. 这些P-PNA有效地抑制了耐药大肠杆菌的生长,因为它们准了像DNA旋转酶和拓聚酶IV这样的重要基因.
科学领域:
- 抗微生物耐药性 抗微生物耐药性
- 分子生物学分子生物学
- 药物发现 药物发现
背景情况:
- 诺基诺 (FQs) 是广泛的抗生素,对于治疗多抗药性 (MDR) 细菌感染至关重要.
- 快速增加的细菌对FQs的耐药性,通常是由于DNA旋酶 (gyrA) 和拓聚酶IV (parC) 的突变,需要新的治疗策略.
- 针对FQ耐药感染的治疗选择有限,突显出迫切需要新型抗生素替代品.
研究的目的:
- 评估旨在抑制DNA旋转酶和托波酶IV的抗感性-核酸 (P-PNA) 的杀菌效果.
- 评估P-PNAs作为一种针对FQ耐药细菌的新型治疗方法的潜力.
主要方法:
- 开发含有细菌透的反感性P-PNA合物.
- 针对 gyrA 和 parC 基因的翻译启动部位和编码序列的 P-PNA 设计.
- 评估这些P-PNAs对抗FQ耐药的大肠杆菌 (FRE) 隔离物的抗菌活性.
主要成果:
- 特定的反意义P-PNAs (ASP-gyrA1,ASP-parC1) 通过准翻译启动部位,有效地抑制了FRE分离物的生长.
- 其他P-PNAs (ASP-gyrA3,ASP-parC2) 通过结合 gyrA 和 parC 基因内的特定编码序列,显示出选择性的杀菌作用.
- 该研究证实了设计的P-PNA对FRE的显著增长抑制和杀菌活性.
结论:
- 有针对性的反意义P-PNA显示出作为有效的抗生素替代品的巨大潜力.
- 这些P-PNA提供了一种有希望的策略来对抗由FQ耐药细菌引起的感染.
- 这些发现支持开发P-PNAs用于对抗耐药细菌菌株的临床应用.
更多相关视频
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
9.6K
11:19Inducing a Site Specific Replication Blockage in E. coli Using a Fluorescent Repressor Operator System
Published on: August 21, 2016
9.0K
相关概念视频
01:28Gene Regulation in Microbial Communities: Quorum Sensing
43
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
43
01:30Development of Antibiotic Resistance
42
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
42
01:23Stringent Response in E. coli
31
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
31